Trade BeyondSpring Inc. - BYSI CFD
Add to favourite- Summary
- Historical Data
- Events
- Income Statement
- Balance Sheet
- Cash Flow
Spread | 0.1850 | ||||||||
Long position overnight fee
Long position overnight fee
Go to platform | -0.026179% | ||||||||
Short position overnight fee
Short position overnight fee
Go to platform | 0.003957% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
*Information provided by Capital.com
Beyondspring Inc ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Prev. Close* | 3.3375 |
Open* | 3.4775 |
1-Year Change* | 219.3% |
Day's Range* | 3.3675 - 3.5575 |
52 wk Range | 0.65-3.45 |
Average Volume (10 days) | 34.41K |
Average Volume (3 months) | 964.44K |
Market Cap | 35.03M |
P/E Ratio | -100.00K |
Shares Outstanding | 38.92M |
Revenue | 1.35M |
EPS | -0.85 |
Dividend (Yield %) | N/A |
Beta | -0.14 |
Next Earnings Date | Feb 28, 2024 |
All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Mar 28, 2024 | 3.4175 | -0.0700 | -2.01% | 3.4875 | 3.5875 | 3.2575 |
Mar 27, 2024 | 3.3375 | -0.2700 | -7.48% | 3.6075 | 3.6175 | 3.3375 |
Mar 26, 2024 | 3.4475 | 0.1200 | 3.61% | 3.3275 | 3.7175 | 3.1875 |
Mar 25, 2024 | 3.3175 | 0.3000 | 9.94% | 3.0175 | 3.4575 | 2.8475 |
Mar 22, 2024 | 3.0475 | 0.3000 | 10.92% | 2.7475 | 3.0775 | 2.7475 |
Mar 21, 2024 | 2.8675 | -0.2200 | -7.13% | 3.0875 | 3.0875 | 2.7975 |
Mar 20, 2024 | 2.9275 | -0.0400 | -1.35% | 2.9675 | 3.1275 | 2.7675 |
Mar 19, 2024 | 3.0175 | 0.0600 | 2.03% | 2.9575 | 3.2675 | 2.7175 |
Mar 18, 2024 | 2.7775 | -0.1000 | -3.48% | 2.8775 | 2.9475 | 2.7475 |
Mar 15, 2024 | 2.7375 | -0.0800 | -2.84% | 2.8175 | 2.9575 | 2.7375 |
Mar 14, 2024 | 2.7575 | -0.1400 | -4.83% | 2.8975 | 2.9675 | 2.7575 |
Mar 13, 2024 | 2.9575 | 0.1000 | 3.50% | 2.8575 | 2.9675 | 2.6875 |
Mar 12, 2024 | 2.9375 | -0.0200 | -0.68% | 2.9575 | 3.0075 | 2.6675 |
Mar 11, 2024 | 2.9575 | 0.0900 | 3.14% | 2.8675 | 3.0375 | 2.7775 |
Mar 8, 2024 | 2.8175 | 0.0600 | 2.18% | 2.7575 | 2.8975 | 2.6175 |
Mar 7, 2024 | 2.7575 | -0.6100 | -18.11% | 3.3675 | 3.3675 | 2.4375 |
Mar 6, 2024 | 3.3575 | 0.4800 | 16.68% | 2.8775 | 3.9375 | 2.7375 |
Mar 5, 2024 | 2.6775 | 1.0200 | 61.54% | 1.6575 | 3.0875 | 1.6575 |
Mar 4, 2024 | 1.5475 | 0.0500 | 3.34% | 1.4975 | 1.8675 | 1.4175 |
Mar 1, 2024 | 1.4475 | 0.1700 | 13.31% | 1.2775 | 1.5375 | 1.2775 |
BeyondSpring Inc. Events
Time (UTC) | Country | Event |
---|---|---|
Thursday, April 18, 2024 | ||
Time (UTC) 20:00 | Country US
| Event Full Year 2023 Beyondspring Inc Earnings Release Full Year 2023 Beyondspring Inc Earnings ReleaseForecast -Previous - |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total revenue | 1.351 | 1.351 | 0.18 | 0 | 0 |
Revenue | 1.351 | 1.351 | 0.18 | 0 | 0 |
Total Operating Expense | 38.59 | 66.956 | 64.391 | 40.307 | 57.545 |
Selling/General/Admin. Expenses, Total | 13.008 | 30.703 | 22.598 | 8.965 | 5.927 |
Research & Development | 25.582 | 36.888 | 41.793 | 31.342 | 51.618 |
Operating Income | -37.239 | -65.605 | -64.211 | -40.307 | -57.545 |
Interest Income (Expense), Net Non-Operating | -0.251 | 0.242 | 0.386 | -0.026 | -0.244 |
Gain (Loss) on Sale of Assets | |||||
Net Income Before Taxes | -36.117 | -64.638 | -63.821 | -40.333 | -57.474 |
Net Income After Taxes | -36.28 | -68.208 | -63.821 | -40.333 | -57.474 |
Minority Interest | 3.001 | 4.029 | 2.848 | 2.248 | 2.605 |
Net Income Before Extra. Items | -33.279 | -64.179 | -60.973 | -38.085 | -54.869 |
Net Income | -33.279 | -64.179 | -60.973 | -38.085 | -54.869 |
Income Available to Common Excl. Extra. Items | -33.279 | -64.179 | -60.973 | -38.085 | -54.869 |
Income Available to Common Incl. Extra. Items | -33.279 | -64.179 | -60.973 | -38.085 | -54.869 |
Dilution Adjustment | |||||
Diluted Net Income | -33.279 | -64.179 | -60.973 | -38.085 | -54.869 |
Diluted Weighted Average Shares | 39.0933 | 39.0236 | 29.9843 | 24.6457 | 22.6653 |
Diluted EPS Excluding Extraordinary Items | -0.85127 | -1.64462 | -2.0335 | -1.5453 | -2.42084 |
Dividends per Share - Common Stock Primary Issue | |||||
Diluted Normalized EPS | -0.85127 | -1.6552 | -2.0335 | -1.5453 | -2.42084 |
Other, Net | 1.373 | 0.725 | 0.004 | 0 | 0.315 |
Total Extraordinary Items | 0 | ||||
Unusual Expense (Income) | -0.635 |
Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total revenue | 1.351 | 0.676 | 0.338 | 0.337 | 0.338 |
Revenue | 1.351 | 0.676 | 0.338 | 0.337 | 0.338 |
Total Operating Expense | 38.59 | 21.484 | 10.83 | 18.686 | 20.317 |
Selling/General/Admin. Expenses, Total | 13.008 | 7.492 | 5.044 | 10.227 | 8.985 |
Research & Development | 25.582 | 13.992 | 5.786 | 8.459 | 11.332 |
Operating Income | -37.239 | -20.808 | -10.492 | -18.349 | -19.979 |
Interest Income (Expense), Net Non-Operating | -0.251 | -0.326 | 0.138 | 0.045 | 0.082 |
Other, Net | 1.373 | 1.259 | 0.608 | 0.749 | 0.003 |
Net Income Before Taxes | -36.117 | -19.875 | -9.746 | -17.555 | -19.894 |
Net Income After Taxes | -36.28 | -20.164 | -10.728 | -20.143 | -19.894 |
Minority Interest | 3.001 | 1.675 | 1.215 | 1.773 | 0.586 |
Net Income Before Extra. Items | -33.279 | -18.489 | -9.513 | -18.37 | -19.308 |
Net Income | -33.279 | -18.489 | -9.513 | -18.37 | -19.308 |
Income Available to Common Excl. Extra. Items | -33.279 | -18.489 | -9.513 | -18.37 | -19.308 |
Income Available to Common Incl. Extra. Items | -33.279 | -18.489 | -9.513 | -18.37 | -19.308 |
Diluted Net Income | -33.279 | -18.489 | -9.513 | -18.37 | -19.308 |
Diluted Weighted Average Shares | 39.0933 | 39.0657 | 39.054 | 39.0249 | 39.0109 |
Diluted EPS Excluding Extraordinary Items | -0.85127 | -0.47328 | -0.24359 | -0.47073 | -0.49494 |
Diluted Normalized EPS | -0.85127 | -0.47328 | -0.24359 | -0.47073 | -0.49494 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total Current Assets | 38.523 | 75.123 | 113.4 | 40.862 | 5.871 |
Cash and Short Term Investments | 37.268 | 72.368 | 109.537 | 35.933 | 3.889 |
Cash | 109.537 | 35.933 | 3.889 | ||
Prepaid Expenses | 1.255 | 2.755 | 3.863 | 4.929 | 1.982 |
Other Current Assets, Total | |||||
Total Assets | 46.222 | 81.648 | 117.038 | 44.555 | 7.063 |
Property/Plant/Equipment, Total - Net | 7.352 | 3.406 | 2.358 | 2.747 | 0.282 |
Property/Plant/Equipment, Total - Gross | 7.903 | 3.725 | 2.616 | 2.928 | 0.386 |
Accumulated Depreciation, Total | -0.551 | -0.319 | -0.258 | -0.181 | -0.104 |
Other Long Term Assets, Total | 0.347 | 3.119 | 1.28 | 0.946 | 0.91 |
Total Current Liabilities | 7.352 | 15.155 | 13.766 | 10.053 | 16.445 |
Accounts Payable | 1.081 | 1.656 | 2.216 | 2.537 | 9.586 |
Accrued Expenses | 4.782 | 6.625 | 9.473 | 6.398 | 5.495 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0.029 | 0 |
Other Current Liabilities, Total | 1.489 | 5.305 | 2.077 | 1.089 | 1.364 |
Total Liabilities | 52.201 | 54.964 | 28.698 | 14.278 | 14.829 |
Total Long Term Debt | 0 | 0 | 2.167 | 1.436 | 0 |
Minority Interest | 2.972 | -0.307 | 3.481 | 0.854 | -1.616 |
Total Equity | -5.979 | 26.684 | 88.34 | 30.277 | -7.766 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.003 | 0.002 |
Additional Paid-In Capital | 368.857 | 369.2 | 366.451 | 246.979 | 170.95 |
Retained Earnings (Accumulated Deficit) | -375.276 | -341.997 | -277.818 | -216.845 | -178.76 |
Other Equity, Total | 0.436 | -0.528 | -0.297 | 0.14 | 0.042 |
Total Liabilities & Shareholders’ Equity | 46.222 | 81.648 | 117.038 | 44.555 | 7.063 |
Total Common Shares Outstanding | 38.9996 | 38.9276 | 39.1419 | 27.8856 | 23.1846 |
Short Term Investments | 2.872 | 30.743 | 0 | ||
Long Term Debt | 0 | 2.167 | 1.436 | ||
Other Liabilities, Total | 41.877 | 40.116 | 9.284 | 1.935 | |
Cash & Equivalents | 34.396 | 41.625 | |||
Current Port. of LT Debt/Capital Leases | 0 | 1.569 | |||
Unrealized Gain (Loss) | 0 | 0.005 |
Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
---|---|---|---|---|---|
Total Current Assets | 38.523 | 55.729 | 75.123 | 94.668 | 79.842 |
Cash and Short Term Investments | 37.268 | 51.937 | 72.368 | 91.6 | 76.306 |
Cash | |||||
Prepaid Expenses | 1.255 | 3.792 | 2.755 | 3.068 | 3.536 |
Total Assets | 46.222 | 63.765 | 81.648 | 98.369 | 82.534 |
Property/Plant/Equipment, Total - Net | 7.352 | 7.922 | 3.406 | 2.333 | 1.296 |
Property/Plant/Equipment, Total - Gross | 7.903 | 3.725 | 2.645 | 1.591 | |
Accumulated Depreciation, Total | -0.551 | -0.319 | -0.312 | -0.295 | |
Other Long Term Assets, Total | 0.347 | 0.114 | 3.119 | 1.368 | 1.396 |
Total Current Liabilities | 7.352 | 11.109 | 15.155 | 18.557 | 16.571 |
Accounts Payable | 1.081 | 1.161 | 1.656 | 2.128 | 2.153 |
Accrued Expenses | 4.782 | 3.513 | 6.625 | 10.311 | 10.444 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | |
Other Current Liabilities, Total | 1.489 | 6.435 | 5.305 | 4.566 | 1.79 |
Total Liabilities | 52.201 | 55.657 | 54.964 | 60.038 | 27.226 |
Total Long Term Debt | 0 | 0 | 0 | 0 | |
Long Term Debt | 0 | 0 | 0 | ||
Minority Interest | 2.972 | 3.627 | -0.307 | 0.83 | 2.487 |
Other Liabilities, Total | 41.877 | 40.921 | 40.116 | 40.651 | 8.168 |
Total Equity | -5.979 | 8.108 | 26.684 | 38.331 | 55.308 |
Common Stock | 0.004 | 0.004 | 0.004 | 0.004 | 0.004 |
Additional Paid-In Capital | 368.857 | 368.473 | 369.2 | 371.209 | 369.784 |
Retained Earnings (Accumulated Deficit) | -375.276 | -360.486 | -341.997 | -332.484 | -314.114 |
Other Equity, Total | 0.436 | 0.117 | -0.523 | -0.398 | -0.366 |
Total Liabilities & Shareholders’ Equity | 46.222 | 63.765 | 81.648 | 98.369 | 82.534 |
Total Common Shares Outstanding | 38.9996 | 38.9554 | 38.9276 | 39.1423 | 39.1419 |
Cash & Equivalents | 34.396 | 30.74 | 41.625 | 63.434 | 51.306 |
Current Port. of LT Debt/Capital Leases | 0 | 1.569 | 1.552 | 2.184 | |
Short Term Investments | 2.872 | 21.197 | 30.743 | 28.166 | 25 |
- Annual
- Quarterly
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Net income/Starting Line | -36.28 | -68.208 | -63.821 | -40.333 | -57.474 |
Cash From Operating Activities | -28.151 | -47.242 | -43.745 | -48.162 | -39.955 |
Cash From Operating Activities | 0.232 | 0.061 | 0.077 | 0.077 | 0.048 |
Non-Cash Items | 1.488 | 2.497 | 8.194 | 2.101 | 6.253 |
Changes in Working Capital | 7.76 | -11.625 | 2.53 | -10.007 | 11.218 |
Cash From Investing Activities | 18.247 | -20.413 | -0.052 | -0.004 | 2.867 |
Capital Expenditures | -0.034 | -2.844 | -0.052 | -0.004 | -0.207 |
Other Investing Cash Flow Items, Total | 18.281 | -17.569 | 0 | 0 | 3.074 |
Cash From Financing Activities | 3.431 | 0.001 | 117.835 | 80.171 | 13.245 |
Financing Cash Flow Items | 0 | -0.082 | -0.645 | 3.33 | -0.755 |
Issuance (Retirement) of Stock, Net | 5 | 0.083 | 117.81 | 69.454 | 14 |
Foreign Exchange Effects | -0.756 | -0.258 | -0.434 | 0.039 | 0.251 |
Net Change in Cash | -7.229 | -67.912 | 73.604 | 32.044 | -23.592 |
Issuance (Retirement) of Debt, Net | -1.569 | 0 | 0.67 | 7.387 | |
Deferred Taxes | -1.351 | 30.033 | 9.275 | ||
Cash Interest Paid | 0.017 | 0.091 | 0.085 |
Dec 2022 | Jun 2022 | Dec 2021 | Sep 2021 | Jun 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | -36.28 | -68.208 | -57.48 | -37.337 | |
Cash From Operating Activities | -28.151 | -47.242 | -30.324 | -33.152 | |
Cash From Operating Activities | 0.232 | 0.061 | 0.054 | 0.037 | |
Deferred Taxes | -1.351 | 30.033 | 30.026 | -0.676 | |
Non-Cash Items | 1.488 | 2.497 | 4.938 | 3.792 | |
Cash Interest Paid | 0.017 | 0.091 | 0.071 | 0.043 | |
Changes in Working Capital | 7.76 | -11.625 | -7.862 | 1.032 | |
Cash From Investing Activities | 18.247 | -20.413 | -15.684 | -25.022 | |
Capital Expenditures | -0.034 | -2.844 | -0.039 | -0.022 | |
Other Investing Cash Flow Items, Total | 18.281 | -17.569 | -15.645 | -25 | |
Cash From Financing Activities | 3.431 | 0.001 | 0.001 | 0.001 | |
Financing Cash Flow Items | 0 | -0.082 | -0.082 | -0.082 | |
Issuance (Retirement) of Stock, Net | 5 | 0.083 | 0.083 | 0.083 | |
Issuance (Retirement) of Debt, Net | -1.569 | 0 | 0 | 0 | |
Foreign Exchange Effects | -0.756 | -0.258 | -0.096 | -0.058 | |
Net Change in Cash | -7.229 | -67.912 | -46.103 | -58.231 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
BeyondSpring Inc. Company profile
About Beyondspring Inc
BeyondSpring Inc. is a global biopharmaceutical company that is focused on developing immuno-oncology cancer therapies. The Company’s lead product Plinabulin, which is being studied as an anti-cancer agent in combination with docetaxel in advanced non-small cell lung cancer (NSCLC). The Plinabulin product is a marine-derived small-molecule selective immunomodulating microtubule-binding agent (SIMBA) with a range of immune activities. Its Plinabulin has the immune defense protein, GEF-H1, which leads to two effects: a durable anti-cancer benefits due to the maturation of dendritic cells resulting in activation of tumor antigen-specific T-cells to target cancer cells and early-onset action in chemotherapy-induced neutropenia (CIN) prevention after chemotherapy by boosting the number of hematopoietic stem/progenitor cells (HSPCs).
Financial summary
BRIEF: For the nine months ended 30 September 2021,Beyondspring Inc revenues increased from $0K to $1M. Netloss increased 26% to $54.7M. Revenues reflect an increasein demand for the Company's products and services due tofavorable market conditions. Higher net loss reflectsGeneral and administrative - Balancing increase from $10.2Mto $22M (expense), Stock-based Compensation in SGA increaseof 76% to $3.7M (expense).
Industry: | Bio Therapeutic Drugs |
28 Liberty Street
39th Floor
NEW YORK
NEW YORK 10005
US
Income Statement
- Annual
- Quarterly
News
A way forward: a roundup of recent central bank decisions
Five of the world’s most significant central banks delivered policy this week. We review the decisions and discuss their impact on the markets.
12:47, 22 March 2024Bank of Japan Preview: will the BOJ end negative interest rates?
The Bank of Japan meets on Tuesday 19th of March. We preview what to expect from the BOJ decision and how it might impact the USD/JPY and Nikkei 225.
08:44, 18 March 2024Higher CPI leaves traders unfazed as US equities continue to build momentum
The latest US CPI reading hasn’t gone how the Federal would have hoped. Consumer prices came in higher than expected in February for the third month in a row.
12:42, 15 March 2024Four reasons why Bitcoin is surging to record highs
Bitcoin has surged to record highs. We discuss the four factors pushing Bitcoin higher and analyse the technicals of the cryptocurrency’s technicals.
10:18, 14 March 2024China’s National People’s Congress: The markets have again been left wanting more
China’s National People’s Congress (NPC) is underway, and the markets have so far been disappointed by what’s been delivered by the country’s central government. We look at some of the significant takeaways from the event, discuss China’s current economic conditions, and analyse the China A50.
08:23, 8 March 2024Central Banks: which one will cut first?
Central banks dominate the calendar in March and markets try to anticipate which one will be the first one to cut
13:14, 6 March 2024Nvidia (NVDA) confronts high expectations for Q4 results
Nvidia is arguably the hottest company on the planet. The company reports its Q4 results after the closing bell on Wednesday, the 21st of February. We preview what to expect from Nvidia’s earnings and analyse the technicals of its stock price.
12:13, 20 February 2024People also watch
Still looking for a broker you can trust?
Join the 580.000+ traders worldwide that chose to trade with Capital.com